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Abstract
Background: Mater (Maternal Antigen that Embryos Require), also known as Nalp5 (NACHT,
leucine rich repeat and PYD containing 5), is an oocyte-specific maternal effect gene required for
early embryonic development beyond the two-cell stage in mouse. We previously characterized
the bovine orthologue MATER as an oocyte marker gene in cattle, and this gene was recently
assigned to a QTL region for reproductive traits.
Results: Here we have analyzed gene expression during folliculogenesis and preimplantation
embryo development. In situ hybridization and immunohistochemistry on bovine ovarian section
revealed that both the transcript and protein are restricted to the oocyte from primary follicles
onwards, and accumulate in the oocyte cytoplasm during follicle growth. In immature oocytes,
cytoplasmic, and more precisely cytosolic localization of MATER was confirmed by
immunohistochemistry coupled with confocal microscopy and immunogold electron microscopy.
By real-time PCR, MATER messenger RNA was observed to decrease strongly during maturation,
and progressively during the embryo cleavage stages; it was hardly detected in morulae and
blastocysts. The protein persisted after fertilization up until the blastocyst stage, and was mostly
degraded after hatching. A similar predominantly cytoplasmic localization was observed in
blastomeres from embryos up to 8-cells, with an apparent concentration near the nuclear
membrane.
Conclusion: Altogether, these expression patterns are consistent with bovine MATER protein
being an oocyte specific maternal effect factor as in mouse.
Background
Preimplantation embryo development is largely depend-
ent on maternal transcripts and proteins synthesized dur-
ing oogenesis. Maternal factors are able to support the first
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cleavages, while blastocyst formation involves both
maternal and embryonic factors. Over the last years,
oocyte-restricted maternal effect genes have been the
focus of much attention due to their specific expression
profile and crucial function in early embryo development.
They are predominantly expressed in oocyte, remain
present in early embryos and then are degraded at the
time of maternal-to-embryo transition (MET), without
compensation by embryonic transcription. Functional
studies based on knock-out mouse models have demon-
strated their essential role in preimplantation embryo
development, whereas functions in the oocyte itself have
not been elucidated until this day.
Mater (Maternal Antigen that Embryos Require) is one
such oocyte-specific maternal effect genes and was first
identified in mouse [1,2]. The transcript and protein
expression profiles have been investigated during oogene-
sis and preimplantation embryo development. Mater
transcript and protein are first detected in oocyte from pri-
mary follicles and accumulate during oocyte growth. The
transcript level decreases after fertilization as shown by
ribonuclease protection assay or DNA array [3,4]). The
protein remains abundant until the morula stage and is
still present in blastocysts [3]. Mater-null females present
a normal phenotype regarding folliculogenesis, ovulation
and fertilization, but their embryos do not develop
beyond the 2-cell stage coincident with the maternal-to-
embryo transition. Mater precise function remains to be
elucidated, although the global transcription decrease
described in two-cell embryos lacking MATER may sug-
gest a role in embryonic genome activation [2]. In our pre-
vious work, we identified the bovine orthologue of Mater.
The longest open reading frame encodes a putative pro-
tein of 1098 amino acids (121 kDa). As its human coun-
terpart, bovine MATER includes the 3 domains
characteristics of the Nacht, Leucine rich repeat and Pyrin
domain containing (NALP) family: a N-terminal Pyrin
domain, followed by a NACHT domain and twelve C-ter-
minal leucine rich repeats of the ribonuclease inhibitor
subtype (LRR-RI). It is localized within a QTL region for
reproductive traits [5]. MATER transcript pattern, i.e. its
tissue distribution and its disappearance in blastocyst,
appeared in agreement with bovine MATER also being an
oocyte-specific maternal effect gene and suggested a con-
served function as in mouse.
To reinforce this hypothesis, we needed to refine tran-
script expression during folliculogenesis, and mostly to
characterize the expression and localization of the pro-
tein. In this study, we show that bovine MATER transcript
and protein are expressed in the oocyte as early as the pri-
mary follicle stage and accumulate during folliculogene-
sis. The protein localizes in the cytosol of immature
oocytes. It remains abundant in the cytoplasm of preim-
plantation embryos until the blastocyst stage and is
mostly degraded after hatching.
Results
Antibody characterization
First, we checked our antipeptide serum and purified anti-
body for sensitivity and specificity by western blotting
(Fig. 1). Under normal exposure, a single intense band
was detected at the MATER protein predicted molecular
weight (121 kDa) with as few as 10 oocytes. No such band
was detected in a protein extract from cumulus cells in
huge excess (see the amount of TUBULIN), although faint
bands were observed at various molecular weights. Specif-
icity was further confirmed by the absence of MATER sig-
nal in oocytes using preimmune serum.
MATER expression throughout folliculogenesis
The expression of MATER transcript during folliculogene-
sis was analysed using in situ hybridization onto ovarian
sections. As previously described [6], MATER expression
was restricted to the oocyte within bovine ovary. In this
experiment, a signal could be detected in oocyte as early
as the primary follicle stage and at a higher level in oocyte
Characterization of anti-MATER serum and purified antibody  by Western blot Figure 1
Characterization of anti-MATER serum and purified 
antibody by Western blot. Detection of MATER in imma-
ture oocytes (IO) but not in cumulus cells (Cc) with anti-
peptide serum or purified antibody, nor with the preimmune 
serum. Molecular weight is indicated on the left.
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antibody
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from antral follicle. Hybridization with the corresponding
sense probe was used as negative control (Fig. 2).
To further characterize MATER gene expression during fol-
liculogenesis, we studied its expression pattern at the pro-
tein level. Using anti-MATER serum, the protein was
exclusively detected in oocyte and no staining was
observed in granulosa or theca cells. MATER was detected
in oocyte of primary follicles at a low level, with a very dis-
tinctive pattern: the staining localized to a single dot (Fig.
3A) which was specifically and reproductively observed.
As folliculogenesis proceeds, staining intensity increases
in oocyte from preantral to small antral and antral folli-
cles (Fig. 3B–D), suggesting an accumulation of the pro-
tein. Interestingly, on sections that went through the
nucleus in pre-antral and early antral follicles, the protein
appeared excluded from the germinal vesicle (Fig. 3B, C).
MATER expression during preimplantation embryo 
development
Evolution of MATER messenger RNAs during during
oocyte maturation, fertilization and preimplantation
embryo development was followed by real time PCR.
Triplicate reactions were run onto four independent sam-
ples at each stage. The level relative to immature oocytes
is shown (Fig. 4A). Detection level decreased by 72% dur-
ing maturation, then remained stable during fertilization.
It decreased progressively during the cleavage stages, up to
10% of its initial level in 5 to 8 cell-embryos. In morulae
and blastocysts, amplicons were produced only in one or
two samples; the level of polyadenylated transcript was
less than 0.5% of its initial value. Western blotting was
then performed to characterize MATER protein expression
(Fig. 4B). MATER was abundant during oocyte matura-
tion, and after fertilization until the expanded blastocyst
stage. Most protein was then degraded after hatching. This
pattern was reproducibly observed with two independent
oocyte and embryo collections. By contrast, our positive
control β-TUBULIN increased in hatched blastocysts (Fig.
4B).
MATER protein localization in oocyte and 
preimplantation embryos
Immunohistochemistry onto ovary sections suggested
that MATER could be predominantly cytoplasmic. To
refine protein localization, we performed confocal micro-
scopy analysis on oocytes from 3 to 8 mm follicles and
preimplantation embryos, after immunofluorescent stain-
ing using purified antipeptide (Fig. 5). Firstly, we
observed oocytes at germinal vesicle (GV) and nuclear
envelope break down (NEBD) stages, as discriminated by
LAMIN A/C staining (Fig. 5A). In most GV oocytes,
MATER protein was predominantly localized in the cyto-
plasm (Fig. 5A, left panel); however, a few oocytes (less
than 10%) presented a distinct pattern, with staining
within both the cytoplasm and the nucleus (Fig. 5A, mid-
dle panel). In oocytes characterized by degradation of
LAMIN A/C (Fig. 5A, right panel), MATER was distributed
throughout the oocyte, only excluded from the chromatin
area as revealed by Hoechst staining. Then we analysed
mature oocytes, zygotes and preimplantation embryos
(Fig. 5B). MATER was predominantly detected in the cyto-
plasm, with the protein apparently concentrating in the
cortical region of mature oocytes, zygotes and embryos at
least until the 8-cell stage. In zygotes to 8-cell embryos,
increased staining around the chromatin area (as revealed
by Hoechst staining, not shown) suggested that MATER
also accumulated around the nuclear membrane. In
expanded blastocysts, MATER was distributed evenly
between inner cell mass and trophectoderm. A dramatic
decrease was observed in hatched blastocysts, as previ-
ously observed by Western blotting. As negative control,
Ovarian localization of bovine MATER transcript by in situ  hybridization Figure 2
Ovarian localization of bovine MATER transcript by 
in situ hybridization. Bright field (A, D) and dark field (B, 
C, E, F) photomicrographs of adjacent ovarian sections 
showing primary follicles (A-C, arrows), and an antral follicle 
(D-F) hybridized with either antisense (A, B, D, E) or sense 
(C, F) MATER-[35S] riboprobes. Scale bar: 100 μm.
Primary follicule  Antral follicle 
A D 
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no staining was revealed using rabbit IgG as primary anti-
body (not shown).
To refine MATER protein subcellular localization, trans-
mission electron microscopy analysis was performed on
ultrathin sections of immature oocytes using purified
antipeptide. Immunogold particules were diffusely
present in the cytosol at a low density. MATER protein was
not detected in the nucleus, nor in organelles including
mitochondria (Fig. 6). As a negative control, no particles
were observed when omitting the primary antibody (not
shown).
Discussion
In this study, we characterized the bovine MATER gene
and its expression throughout folliculogenesis and in
vitro preimplantation embryo development. We demon-
strated that both the transcript and protein were present in
oocyte from primary follicle and accumulated thereafter.
During preimplantation embryo development, MATER
messengers were hardly detected after the morula stage,
while the protein remained present until the blastocyst
stage before rapid degradation after hatching. In imma-
ture oocytes and in embryos, the protein was predomi-
nantly cytoplasmic.
MATER gene expression throughout bovine 
folliculogenesis and preimplantation embryo development
In a previous study, we demonstrated that MATER tran-
script was restricted to the oocyte within bovine ovary [6].
Here, we have refined our expression analysis. By in situ
hybridization and immunohistochemistry experiments,
we detected MATER transcript and protein in oocytes as
early as the primary follicle stage (Fig. 2 and 3), as previ-
ously described in mouse [1,3]. This shows that at least
some transcripts support immediate translation, but it
does not exclude that others are stored within the oocyte
cytoplasm. Such an early protein synthesis may appear
premature since functional studies did not reveal a delete-
rious effect of Mater absence at this early stage, but rather
in the 2-cell embryo [2]. Indeed, ZAR1, another mouse
oocyte-specific maternal effect protein, was also detected
in mouse primary follicles [7]. Several scenarios may rec-
oncile these apparent discrepancies. The first hypothesis is
that MATER indeed plays a role in the oocyte, but that
another gene may be redundant at this stage, at least in
Mater-null females. Obvious candidates are genes of the
NALP family, and especially oocyte restricted members
such as NALP9 in bovine [8] or the Nalp9 or Nalp4 genes
in mouse [9,10]. To our knowledge, there are no func-
tional data on these genes from knock-out models or
other targeted inhibition experiments. This early expres-
sion may also be indicative of an upstream role of MATER
in a cascade of events, as demonstrated for the mouse
Ovarian localization of bovine MATER protein by immunohistochemistry Figure 3
Ovarian localization of bovine MATER protein by immunohistochemistry. Adjacent ovarian sections showing pri-
mary follicle (A, E), pre-antral follicle (B, F), early antral follicle (C, G) and over 1 mm antral follicle (D, H) incubated with either 
anti-MATER serum (A-D) or preimmune serum (E-H) followed by biotinylated horse anti-rabbit IgG antibody. Scale bar: 100 
μm. Inset in A is the same oocyte shown at higher magnification.
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oocyte-specific homeobox gene Nobox [11]. Alternatively,
the protein may be synthesized despite not being required
at this stage, simply because specifically repressing the
gene would be more complex for the cell than support
minimal expression. Overall, we observed that immunos-
taining of MATER protein increased in parallel with folli-
cle development, from primary to large antral. This must
involve a growing level of translation; in addition, it is
possible that once synthesized, the protein remains stable
for a long period of time and persists in the oocyte during
folliculogenesis. Neo-synthesized proteins would then
add to those already present, and early synthesis would
allow for the accumulation of a largest stockpile of
MATER.
Localization of MATER protein in bovine oocytes and preim- plantation embryos by confocal microscopy Figure 5
Localization of MATER protein in bovine oocytes and 
preimplantation embryos by confocal microscopy. 
Oocytes and embryos were incubated with anti-MATER pep-
tide purified antibody (1:250) and revealed by green staining. 
Scale bar: 50 μm. (A) Oocytes at GV or NEBD stage. Lamins 
A/C are stained in red (middle row). Chromatin is stained in 
blue with Hoechst 33258 (lower row). (B) immature oocytes 
(IO), in vitro matured oocytes (MO), in vitro cultured zygote 
(1C), 2-, 4-, 8- cell embryos, morula (mo), expanded blasto-
cysts (EB) and hatched blastocysts (HB).
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Expression of bovine MATER in oocytes and preimplantation  embryos Figure 4
Expression of bovine MATER in oocytes and preim-
plantation embryos. Developmental stages are immature 
oocytes (IO), in vitro matured oocytes (MO), in vitro cultured 
zygote (1C), 2-, 4-, 5- to 8- cell embryos, morula (mo), 
expanded blastocysts (EB) and hatched blastocysts (HB). (A) 
Quantification of the messenger RNA using real-time PCR. 
Relative level to immature oocytes is shown (mean ± SEM). 
In late stage embryos, transcript level is indicated but too 
low to be seen on the histogram. Different superscripts indi-
cate a significant difference (P ≤ 0.05). (B) Detection of the 
protein by Western blot; α-TUBULIN is shown as a positive 
control.
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By real-time PCR, bovine MATER transcripts showed a
massive deadenylation and/or degradation during matu-
ration (Fig 4A). Following fertilization, the messengers
slowly decreased in embryos until the 5- to 8-cell stage; it
was hardly detected in morulae and blastocysts, confirm-
ing our previous report [6]. We did not evidence neo-syn-
thesis or polyadenylation of MATER transcripts neither
transiently nor after the MET. By contrast, we have dem-
onstrated by Western-blot and immunofluorescence cou-
pled to confocal microscopy that the protein is present at
all stages, and displays a sharp decrease only after hatch-
ing (Fig. 4 and 5). These distinct patterns for the transcript
and the protein provide valuable information. First, later
persistence of the protein as compared to the messenger is
consistent with MATER being a fairly stable protein. This,
together with the accumulation of MATER during follicu-
logenesis, suggests that at least some protein detected in
early embryos is of maternal origin. Second, degradation
of MATER protein after hatching appears temporally con-
trolled and substrate specific, since most proteins are
rather synthesized at this stage following the MET. The
bovine protein in fact persists longer than its mouse coun-
terpart, which was mostly degraded by the expanded blas-
tocyst stage. This is consistent with active degradation of
MATER involving factors synthesized from embryonic
transcripts in both species. The ubiquitin-proteasome
pathway is one possible mechanism, and ubiquitin tran-
scripts were actually shown to increase in bovine blasto-
cysts [12]. On the other hand, ubiquitin cross-reactive
structures were detected preferentially in the trophoblast
over the the inner cell mass [13] whereas here we observe
a simultaneous degradation of MATER in both structures
at hatching (Fig. 5). Overall, the pattern of expression of
bovine MATER, i.e. non reactivation at MET and degrada-
tion of the protein before implantation, supports the
hypothesis that it is a maternal effect gene as its mouse
orthologue.
MATER protein intracellular localization in bovine oocytes 
and preimplantation embryos
Data from immunohistochemistry on ovary sections sug-
gested that MATER protein was stored in the cytoplasm of
oocyte during folliculogenesis (Fig. 3B, C). Intracellular
localization of MATER was further investigated in oocytes
and early embryos by immunofluorescence coupled to
confocal microscopy analysis (Fig. 5). In most immature
oocytes, MATER was predominantly localized in the cyto-
plasm with an accumulation around the nuclear mem-
brane and was hardly detected in the germinal vesicle. A
few oocytes displayed a different pattern of protein distri-
bution, where MATER was detected both in the cytoplasm
and the germinal vesicle (Fig. 5A). After NEBD, the pro-
tein was uniformly distributed throughout the cytoplasm
and was only excluded from the chromatin area (Fig. 5A).
Such transient nuclear localization of MATER was not
described in mouse oocytes. We propose two hypotheses
consistent with our observations. It may be that MATER
passively diffuses to the germinal vesicle as the nuclear
membrane starts to disaggregate, even though lamins are
still detected. Alternatively, we can speculate that MATER
actively translocates to the nucleus just before NEBD.
MATER sequence does not display a nuclear localization
signal as analyzed by the PredictNLS server [14,15]. But
neither was such signal identified in the mouse oocyte
specific variant of DNA (cytosine-5)-methyl-transferase 1
(Dnmt1o), whose temporarily controlled nucleocytoplas-
mic trafficking was nevertheless demonstrated: this pro-
tein localizes to the cytoplasm of oocytes and
preimplantation embryos with exclusion from all nuclei
except those of 8-cell embryos [16]. MATER might be
involved in the short burst of transcription that has been
Subcellular localization of MATER protein in bovine imma- ture oocytes by transmission electron microscopy Figure 6
Subcellular localization of MATER protein in bovine 
immature oocytes by transmission electron micros-
copy. Immunogold particles are pointed at by arrows. (A) 
region including a mitochondria (B) a detail of the nuclear 
membrane, separating the nucleus (below) and the cytoplasm 
(above).
200nm
A
200nm
B
nuclear
membrane
nucleus
cytoplasm 
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suggested to occur in bovine oocyte-cumulus complexes
just before chromatin condenses [17-19]
Then, we followed MATER localization after oocyte matu-
ration, fertilization and during preimplantation embryo
development (Fig. 5B). Localization was predominantly
cytoplasmic in embryos at least until the 8 cell stage. We
noticed that the protein appeared to concentrate in the
cortical region of mature oocytes and embryos up to 8-
cells, as previously observed in mouse preimplantation
embryos [3]. A similar peripheral concentration had also
been reported for the ovary-specific 2',5'-oligoadenylate
synthetase-like protein (OAS1D) in metaphase II oocytes
[20], and for DNMT1o in mature oocytes, 2- and 4-cell
embryos [16]. The authors suggested that DNMT1o may
be sequestered near the plasma membrane through inter-
action with annexin V, a calcium-sensitive phospholipid
binding protein [16]. MATER includes protein-protein
interacting domains and identifying potential partners
may help elucidating this intriguing distribution.
In GV oocytes, MATER localization was refined by immu-
nogold coupled to transmission electron microscopy
analysis. The protein was detected in the cytosol but not
in organelles (Fig. 6). This pattern differs from MATER dis-
tribution in mouse, where the protein was detected in the
nucleus close to nuclear pores and in mitochondria [3].
Based on the presence of a leucine-rich repreat domain
homologous to a porcine ribonuclease inhibitor, mouse
MATER has been suggested to play a role in mRNA stabil-
ity. Altogether, our observations on bovine MATER distri-
bution are consistent with this hypothesis. In oocytes,
MATER would stabilize transcripts from the moment
when they are exported from the nucleus and during their
storage in the oocyte cytoplasm up until the time when
there are recruited for translation in the oocyte or after fer-
tilization. Through a similar peri-nuclear accumulation in
early embryos, MATER could protect the rare transcripts
produced from the embryonic genome at these stages.
Finally, MATER is degraded after hatching, once the
embryo synthesizes large amount of messengers and pro-
teins. This model is consistent with the phenotype of
embryos from Mater  null female mice: transcripts
required for development beyond the 2-cell stage (e.g. in
genome activation) would not be stabilized, resulting in
developmental block.
Conclusion
We have demonstrated that MATER transcript and protein
are specifically expressed in oocyte from the primary folli-
cle onwards in bovine ovary. The protein is stored in the
cytoplasm of growing oocytes and persists during matura-
tion, fertilization and in embryos until the expanded blas-
tocyst stage. It is mostly degraded after hatching.
Therefore MATER transcript and protein expression pat-
terns are consistent with a maternal effect function con-
served in bovine. Challenging functional approaches are
now required to confirm this hypothesis.
Methods
Oocyte collection and in vitro embryo production
Ovaries from adult cows (unless otherwise specified) were
collected at a slaughterhouse and the oocyte-cumulus
complexes were aspirated from 3–6 mm follicles, selected
based on morphological criteria and washed in saline
solution (for details see [21]). Denuded immature and in
vitro  matured oocytes were obtained as previously
described [22]. Briefly, oocyte-cumulus complexes were
denuded by mechanical treatment either before or after in
vitro maturation in TCM199 (Sigma, Saint Quentin Falla-
vier, France) supplemented with 10 ng/ml epidermal
growth factor and 10% fetal calf serum for 24 hr at 39°C
in water-saturated air with 5% carbon dioxide. For in vitro
fertilization, groups of 50 intact in vitro matured oocyte-
cumulus complexes were transferred into 500 μl fertiliza-
tion medium containing 106 motile spermatozoa. 24 hr
later, presumptive zygotes were denuded. Groups of 25
zygotes were transferred into 25 μl droplets (under paraf-
fin oil) of modified synthetic oviduct fluid supplemented
with 5% fetal calf serum. Embryos were cultured at 39°C
in a water-saturated atmosphere with 5% CO2/5% O2/
90% N2. Groups of 10 embryos were collected over preim-
plantation development period: zygote and 2-cell
embryos (day 2), 4-cell, 5 to 8-cell embryos (day 3),
morulae (day 5), expanded blastocysts (day 6) and
hatched blastocysts (day 8). All oocyte and embryo sam-
ples were stored frozen at -80°C. Two and four independ-
ent sets of oocytes and embryos were collected for
immunological and real-time PCR analyses respectively.
In situ hybridization
Ovaries from 6 month old calves were embedded in Tis-
sue-Tek medium (Sekura, Bayer Diagnostics, France), fro-
zen in liquid nitrogen and then serially sectioned (10 μm)
with cryostat. The sections were fixed in 4% paraformalde-
hyde. A 391 bp MATER PCR fragment (corresponding to
nt 2819–3209 of the coding sequence) was subcloned in
Dual Promoter pCRII plasmid (Invitrogen, Cergy-Ponto-
ise, France). Sense and antisense probes were generated
using Riboprobe combined system SP6/T7 (Promega,
Charbonnières, France) and labelled with [35S]-UTP.
Hybridization and washed were performed as described
elsewhere [23]. Sections were counterstained with hema-
toxylin.
Real-time PCR
After adding 10 pg of luciferase mRNA (Promega) as an
exogenous standard, total DNAse-treated RNA was
extracted from 4 independent pools of 10 oocytes orBMC Developmental Biology 2006, 6:26 http://www.biomedcentral.com/1471-213X/6/26
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embryos at each stage using the Picopure RNA isolation
kit (Alphelys, Plaisir, France). Reverse transcription was
performed using oligo(dT)15 primers (Promega) during
50 min at 37°C by mouse Moloney leukaemia virus
reverse transcriptase (Invitrogen, cergy Pontoise, France).
Target cDNA were then quantified by real-time PCR using
iQ SYBR green supermix (Bio-Rad, Marnes la Coquette,
France) in a MyCycler system (Bio-Rad) using specific
primers for MATER  (forward 5'-GCTGGAGGCGTGT-
GGACTG; reverse 5'-GGTCTGTAGATTAGAGGT-
GGGATGC) and luciferase  (forward 5'-
TCATTCTTCGCCAAAAGCACTCTG; reverse 5'-
AGCCCATATCCTTGTCGTATCCC). A 3-step protocol was
repeated for 40 cycles (95°C for 30 sec, 60°C for 30 sec,
72°C for 20 sec), followed by acquisition of the melting
curve. cDNA amount equivalent to 0.05 oocyte or embryo
was used in triplicate reactions. The standard curve was
deduced from five serial dilutions (100 fg to 0.01 fg) of a
plasmid including the target sequence included in each
run. In each sample, the median value of PCR triplicates
was considered (0 when not detected), and MATER data
was normalized with exogenous luciferase to correct for
loss of RNA; the MATER/luciferase value was then com-
pared to this same ratio in immature oocytes (mean of
four oocyte collections). Data are presented as mean ±
SEM. After analysis of variance, first between immature
oocytes and other stages, then between stages starting
from mature oocyte onwards, differences were considered
statistically significant at the 95% confidence level (P ≤
0,05) using Tukey comparison test.
Immunohistochemistry
A keyhole limpet hemocyanin (KLH)-coupled MATER
peptide (C terminus, aa 1084–1098) was used to immu-
nize rabbits to produce the primary antibody (Eurogentec,
Angers, France). Bovine ovaries were fixed in Bouin solu-
tion (50% saturated picric acid, 3.7% formaldehyde, 5%
acetic acid), embedded in paraffin and serially sectioned
(10 μm). The ovarian sections were immersed in antigen
unmasking solution (Abcys, Paris, France) and warmed
for 6 min in a microwave. After removing endogenous
peroxydase activity in 0,3% H2O2 and blocking with horse
serum, ovarian sections were incubated either with pri-
mary anti-MATER serum or rabbit preimmune serum
(1:10000) overnight at 4°C, followed by incubation for 1
hr at room temperature with secondary biotinylated horse
anti-mouse/rabbit/goat IgG antibody (1:200) (Abcys).
Avidin, biotinylated horseradish peroxydase (HRP) and
diamino-benzidene (DAB) were applied according to the
manufacturer's instructions using Vectastain elite ABC kit
(Abcys). Sections were counterstained with hematoxylin.
Western blot
Pools of 10 oocytes or embryos, or cumulus cells, were
frozen and thawed three times, and then the proteins were
separated on 7.5 or 10% SDS-PAGE gels and transferred
onto a nitrocellulose membrane. After blocking with 5%
dry milk in tris buffered saline, the blot was incubated
with anti-MATER serum (1:10000) or pre-immune serum
(1:10000) or purified antibody (1:2000) overnight at 4°C
under agitation, and subsequently with secondary HRP-
conjugated goat anti-rabbit IgG antibody (1:5000) for 1
hr 30 min at room. The signal was detected using an
enhanced chemiluminescence kit according to the manu-
facturer's instructions (Amersham Biosciences, Orsay,
France). The membranes were stripped and blotted with
an anti-α-TUBULIN monoclonal antibody (Sigma).
Experiment was performed on two independent oocyte
and embryo collections.
Confocal scanning laser microscopy
Oocytes and embryos were fixed for 20 min in 4% para-
formaldehyde. After treatment in phosphate buffered
saline 1X/Triton 0.2% followed by blocking in 5% goat
serum, they were subsequently incubated with either rab-
bit anti-MATER antibody purified onto a peptide affinity
column by the manufacturer (1:250) or rabbit IgG over-
night at 4°C, and then for 1 hr at room temperature with
secondary goat anti-rabbit IgG antibody conjugated to
fluoprobe 488 (1:100) or fluorescein isothiocyanate
(1:400) for immature oocytes (both from Interchim,
Montluçon, France). For LAMIN staining, immature
oocytes were incubated with mouse anti-LAMIN A/C anti-
body (1:200; Ozyme, Saint Quentin Yvelines, France) for
2 hr at room temperature and with secondary Texas Red-
conjugated goat anti-mouse antibody (1:400; Sigma), for
1 hr at room temperature. Chromatin was stained using
Hoechst 33258 (Sigma). Mowiol was used as mounting
medium.
Transmission electron microscopy (TEM)
Immature oocytes were fixed in 4% paraformaldehyde for
20 min at 4°C. Subsequently, they were washed in phos-
phate buffer 0.1 M, incubated in ammonium chloride
0.05 M in phosphate buffer for 30 min at room tempera-
ture and washed in phosphate buffer. Then, oocytes were
dehydrated in ethanol and embedded in LRWhite resin
(London Resin Company, Theale, England). Ultra-thin
sections (80 nm) were placed on 200 mesh formvar-
coated nickel grids and blocked in 10% goat serum and
1% BSA. The grids were then incubated with purified rab-
bit anti-MATER antibody (1:1000) overnight at 4°C,
washed with PBS/0,1% BSA/1% goat serum and incu-
bated with colloidal gold-labelled (18 nm) secondary
goat anti-rabbit antibody (1:10, (Immunotech, Marseille,
France) for 2 hr at room temperature. After several wash-
ing in PBS and deionised water, sections were counter-
stained with 4% uranyl acetate and lead citrate. Specificity
of immunostaining was checked by incubation of sections
with PBS/0,1% BSA/1% goat serum. Sections werePublish with BioMed Central    and   every 
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observed with a CM10 electron microscope (Philips,
Eindhoven, Netherlands).
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